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Counterfeit Equine Drugs
Continue to Show at Track
"Just Say No," the familiar rallying cry in the
nation's drug war now has a place at race tracks,
show rings, and equine clinics across the country.
Despite repeated warnings from the animal
health industry and the U.S. Food and Drug
Administration 7 some cost-conscious consumers
continue to fool themselves and endanger the
horses under their care with unapproved, bargain-
priced products that masquerade as "the real
thing.' ,
The counterfeit products may contain harmful
impurities or ingredients not listed on the
product's label. What's more, veterinarians and
trainers who use them could be held liable for any
harmful side effects they cause.
Most recently, in the upper Midwest, a product
called Arthryl was being marketed as anew,
inexpensive form of hyaluronic acid, a drug
commonly used for treating lameness in race and
event horses.
However, a recent assay by an independent
laboratory revealed that the product contained no
detectable levels of hyaluronate. There was also
evidence that indicated the presence of a steroid,
reports Dr. William Tew, chief technical officer
for Chesapeake Biological Laboratories, Inc.,
Baltimore.
Anhryl is the latest development in the continu-
ing wave of drug counterfeiting that has plagued
the equine industry and endangered the health
and welfare of valuable animals:
According to Dr. John Augsburg of the FDA's
Center for Veterinary Medicine, there have been
reports that some enterprising distributors are
obtaining short-dated or expired legal drugs and
removing the expiration dating, lot numbers, and
the original manufacturer/distributor name and
address segments. The products are then resold at
bargain prices.
Working under cover, FDA investigators con-
tinue to find evidence of drug counterfeiting,
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particularly with anabolic steroids. Last year, for
example, they uncovered a batch of counterfeit
product labeled as Equipoise, a popular, high
quality anabolic steroid marketed by Solvay
Veterinary, Inc. However, no active ingredients
were found in the bogus product.
We've put several other counterfeiters out of
business since then, but the problem certainly
hasn't gone away," reports an FDA investigator,
who requested anonymity to protect the security
of ongoing investigations.
Because the flow of legitimate drugs is being
watched more closely, the black market has resort-
ed to making products of its own. "There was a
time when you could buy legitimate drugs at black
market prices," the FDA investigator adds. "But
now the black market is manufacturing products
of its own, and there's no telling what they're
putting in those vials."
Over the past year, the FDA has confiscated
counterfeit canons and labels, which carried actual
batch numbers copied from legitimate labels print-
ed by established manufacturers.
In 1986, the FDA discovered an equine drug
called Equi-Bold, which had been sold to
veterinarians and trainers as a bargain-priced
anabolic steroid. The Equi-Bold label said the
product contained boldenone undecylenate, the
exclusive active ingredient found in Equipoise.
However, a laboratory assay showed that it
contained either testosterone or nandrolone
decanoate.
It is estimated that unapproved drugs make up
10-15 percent of the animal drug market in the
United States. But according to Dr. Tew, a labora-
tory assay is not always needed to determine if a
drug is counterfeit.
"All you have to do is look at the price," he
says. "No one can make a quality product and sell
it for such ridiculous prices. They couldn't stay in
business.' ,
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According to Julie Stephanus, large animal
business manager at Solvay Veterinary, Anhryl was
being sold at less than 10 percent of the cost of
established, high quality hyaluronic acids such as
Equron.
Dr. Tew, whose laboratory has examined several
illicit drugs, says the problem appears to be more
prevalent in equine circles than in other areas of
animal health.
Why? He offers this candid, philosophical
theory:
"Horse racing is an industry of hope. And in
an industry of hope, there's always someone be-
ing taken for a ride. People are always looking for
a competitive edge - a magic potion that, in their
minds, will put their horse one step ahead of the
competition. "
Over the past two years, crackdowns by the
FDA, FBI, Department of Justice and other
government agencies have reduced the availabil-
ity of these drugs. But ultimately, only consumers
can stop the flow.
"Just say no!" Stephanus suggests. "And only
buy animal drugs from authorized manufac-
turers.' ,
Information on illicit animal drugs or products
with defaced labeling should be brought to the
attention of the nearest FDA Resident Post or
District Office. The telephone number is listed in
most local directories. All leads will be kept
confidential.
For funher information contactJoe Feeks orJulie
Nettifee 914-758-2200 orJulie Stephanus, Solvay
Veterinary 1-800-524-1645.
FDA Issues Warning
About Defaced Drugs
The Food and Drug Administration's Center for
Veterinary Medicine warns that some animal drugs
are being sold at discounted prices in Texas,
Colorado, and Kansas in packaging that has been
defaced. The practice may not be limited to these
three states. According to the information received,
some distributors are purchasing legal! approved
veterinary drugs and removing the expiration
dating, lot numbers, and the original manufac-
rurer / distributor name and address segments from
the labeling panels. FDA asks veterinarians to
beware of these products. They may not be the bar-
gain they appear to be. Carefully examine packages
and containers to be certain they have not been
tampered with or defaced. Information on products
with defaced labeling should be brought to the
attention of the nearest FDA Resident Post or
District Office. Your cooperation is the key to
stopping this illegal practice. Contact: Mary-Alice
Miller, (301) 443-4557.
Repnnted courtesy of the American Vetennary Medical
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